Lead Compounds in Clinical Chemoprevention Conference

Cancer & Cardiovascular Research building
The overall goal of this meeting is to bring together researchers in the process of moving pharmaceuticals into human cancer prevention trials at the University of Minnesota. The event is organized as a combination of presentations of pipeline compounds and biochemical pathways we are currently targeting in cancer prevention and treatment. A focus on barriers to rapid translation and regulatory pathways for clinical adoption will be included. Infrastructure available on campus to facilitate translation will be presented. Finally, after a breakout session, attendees will construct an algorithm to assist attendees with a strategy to move compounds more rapidly to clinic.

The target participants for this meeting are clinicians, researchers, and scientists striving towards adding innovative compounds to the human cancer prevention armamentarium. Those already developing experimental therapeutic strategies are strongly encouraged to attend.
Registration opening spring 2022.
Questions? Contact mccevents@umn.edu.

Expand all

Exhibitor & Sponsor Opportunities

Industry partners are crucial collaborators to scientific progress and are invited to participate as exhibitors. Your support will help us achieve our goals in building this robust event while sharing your products and services with attendees. The deadline to submit intent to exhibit is July 15, 2022. Please review the exhibitor prospectus here. Contact mart2948@umn.edu with questions.